Amgen's Otezla May Be Approved for Broader Use
Amgen Inc. on Tuesday said its psoriasis drug Otezla was approved by the Food and Drug Administration to be used on a wider patient population.
More from California Business
North California Record
Following state appellate ruling involving ADA claims, further relief urged at federal level
California Business
•
Dec 5, 2022
FresnoBee | Business
Here's How to Keep Winter Utility Bills Down as Energy Costs Rise
California Business
•
Dec 5, 2022
East Bay Times | Business
Released Twitter emails show how employees debated how to handle 2020 New York Post Hunter Biden story
California Business
•
Dec 5, 2022